From the Sector

• Revenue grows to EUR 623.1 mn – fiber sales recovered over the course of the quarter
• EBITDA and net result for the period down compared with the first quarter of 2022
• Cost reduction program of more than EUR 70 mn being implemented according to plan
• Production of TENCEL™ brand modal fibers successfully launched in China
• Lenzing confirms guidance for 2023

The business performance of the Lenzing Group during the first quarter of 2023 largely reflected market trends. However, after the market environment had deteriorated significantly in the third and fourth quarters of the previous year, signs of recovery emerged during the first quarter in terms of demand as well as raw material and energy costs. Textile fibers recorded moderate but steadily improving demand. Business with fibers for nonwovens and with dissolving wood pulp performed better than expected. Raw material and energy costs were still at an elevated albeit decreasing level.

Outlook
The war in Ukraine and the more restrictive monetary policy pursued by many central banks in order to combat inflation are expected to continue to influence global economic activity. The IMF warns that risks remain elevated overall and forecasts growth of 2.8 and 3 percent for 2023 and 2024 respectively. The currency environment is expected to remain volatile in the regions relevant to Lenzing.

This market environment continues to weigh on the consumer climate and on sentiment in the industries relevant to Lenzing. However, the outlook has brightened somewhat recently.

Demand picked up tangibly after the Chinese New Year. As a consequence, capacity utilization improved and stocks were further reduced both at viscose producers and at downstream stages of the value chain.

In the trend-setting market for cotton, signs are emerging of a further buildup of stocks in the current 2022/23 crop season. Initial forecasts for 2023/24 anticipate a more balanced relationship between supply and demand.

However, despite signs of recovery in both demand and raw material and energy costs, earnings visibility remains limited overall.

Lenzing is fully on track with the implementation of the reorganization and cost reduction program. These and other measures are aimed at positioning Lenzing in the best possible way for the expected market recovery.

Structurally, Lenzing continues to anticipate growth in demand for environmentally responsible fibers for the textile and clothing industry as well as for the hygiene and medical sectors. As a consequence, Lenzing is very well positioned with its “Better Growth” strategy and plans to continue driving growth with specialty fibers as well as its sustainability goals, including the transformation from a linear to a circular economy model.

The successful implementation of the key projects in Thailand and Brazil as well as the investment projects in China and Indonesia will further strengthen Lenzing’s positioning in this respect.

Taking into account the aforementioned factors and assuming a further market recovery in the current financial year, the Lenzing Group continues to expect EBITDA in a range between EUR 320 mn and EUR 420 mn for 2023.

Highlights Q1 2023 (compared with Q1 2022)

• Revenue up 5% and up 8% in constant currencies1
• Pricing up 7%, more than offsetting increase of raw material and freight costs
• Volumes 3% lower; Europe showing resilience, China rebounding
• Operating income at €182 million (2022: €232 million); adjusted operating income2 at €218 million (2022: €230 million); ROS3 at 8.2% (2022: 9.1%)
• Net cash from operating activities negative €50 million (2022: negative €102 million)
• Intended acquisition of Chinese Decorative Paints business from Sherwin-Williams announced in April 2023; completion expected in the second half of 2023

2023 Outlook
AkzoNobel expects the ongoing macro-economic uncertainties to continue and weigh on organic volume growth. The company will focus on margin management, cost reduction, working capital normalization and de-leveraging.
Cost reduction programs are expected to mitigate the ongoing pressure from inflation in operating expenses for 2023. AkzoNobel expects declining raw material costs to have a favorable impact on profitability.
Based on current market conditions, AkzoNobel targets to deliver €1.2 to €1.5 billion adjusted EBITDA.
The company aims to lower its leverage ratio to less than 3.4 times net debt/EBITDA, including the impact of the Kansai Paint Africa acquisition, by the end of 2023 and return to around 2 times post-2023.

International technology group ANDRITZ has started the 2023 business year with unchanged high growth dynamics despite a slowing global economy. Revenue and operating result both increased significantly by well over 20 percent in the first quarter of 2023 compared with the same period of the previous year. Net income improved by almost 50 percent to 104.5 million euros (MEUR). Order intake reached a favorable level of 2.4 billion euros but was 6.5 percent below the figure for the first quarter of 2022, when the booking of two large-scale orders had provided a peak.

The key financial figures developed as follows during the reporting period:

• Order intake amounted to 2,420.2 MEUR and was thus 6.5% below the high level of the previous year’s reference period (Q1 2022: 2,588.6 MEUR), which included two large-scale orders. The Metals business area was able to increase its order intake significantly compared to the previous year’s reference period.
• The order backlog as of March 31, 2023 amounted to 10,407.8 MEUR and has thus increased compared to 2022 (December 31, 2022: 9,976.5 MEUR).
• Revenue at 1,962.6 MEUR was 28.5% higher than the reference figure for the previous year’s reference period (Q1 2022: 1,526.9 MEUR). All four business areas were able to significantly increase their revenue compared to the previous year.
• The operating result (EBITA) increased in line with revenue, reaching a very favorable level at 158.5 MEUR in the first quarter of 2023 (+29.6% versus Q1 2022: 122.3 MEUR). The Group’s profitability (EBITA margin) increased slightly to 8.1% (Q1 2022: 8.0%).
• Net income (without non-controlling interests) increased significantly to 104.5 MEUR (Q1 2022: 71.5 MEUR).

Following the successful first quarter, ANDRITZ confirms its previously published outlook for the full year 2023. Both revenue and earnings for the full year are expected to be above the level of 2022.

Around EUR 355 million in overall turnover, 350 extruders delivered creating an additional recycling capacity for 1.6 million tons of recycled pellets as a result - these are the figures with which the EREMA Group was able to close the 2022/23 financial year in March.

"With demand for recycled plastics remaining high, the past financial year brought many challenges that we needed to handle," says Manfred Hackl, CEO of EREMA Group GmbH. The challenges included persistent delays in the supply chain and unexpected supplier outages. Logistics and production processes had to be adapted several times as a result. The situation has improved significantly meantime as a result of these measures and more stable supply chains.

The production locations in Austria manufactured 270 extruders and delivered them to customers around the globe. Taking the whole group into consideration, this figure rises to 350 including the extruders from PLASMAC, the Italian subsidiary. The recycled pellet production capacity of all extrusion systems delivered in financial year 2022/23 adds up to around 1.6 million tonnes per year. On top of that there are around 130 additional components and modules such as filter systems and ReFresher anti-odour units.

Recycling innovations for high-quality pellets
K 2022 - the highlight trade fair of the past financial year - saw the EREMA Group launch seven
new recycling systems and components. These included the new INTAREMA® TVEplus® DuaFil® Compact recycling system and the EcoGentle® plasticising unit, which was also newly developed. Thanks to their gentle polymer treatment and significantly lower melt temperature, both extrusion innovations deliver effective advantages in terms of the quality of the melt, recycled pellets, and final product, as well as impressive energy efficiency in post consumer and PET recycling applications. The significance of these innovations for plastics recycling is underlined by the nomination of the DuaFil® Compact technology for one of this year's Plastics Recycling Awards Europe in the category Recycling Machinery Innovation of the Year.
The same applies to the READYMAC 1109 TVE machine made to stock by EREMA Group subsidiary UMAC, as well as to the new ALPHA XS edge trim recycling machine for the inhouse recycling segment made by PLASMAC. The market launch of the deinking system presented at K 2022 by the EREMA Group company KEYCYCLE delivering a throughput of 1,200 kilograms per hour has been a success, as has the commissioning of a further unit sold to a film manufacturer.

40 years of EREMA
The beginning of the new financial year falls almost to the day on EREMA's 40th anniversary. On 14 April 1983, Helmut Bacher, Helmuth Schulz and Georg Wendelin founded EREMA Engineering Recycling Maschinen und Anlagen GesmbH, laying the foundation for the 40-year success story. In celebration, the comapny will hold the event EREMA Discovery Day at the company headquarters on the 1st of June. This event with live insights into the latest post consumer and PET recycling technologies will also see the official opening of the newly built research and development centre.

The international association that will manage the Single-Entry-Point (SEP) of the BIONANOPOLYS project has been formally constituted and will be able to support companies across the European Union in the market introduction of bionanomaterials through technical, legal, regulatory, safety, economic and financial support services.

The SEP was established as an AISBL (non-profit entity) on 17 February 2023 in the framework of the European project BIONANOPOLYS, funded by the Horizon 2020 programme. The technical director of ITENE and coordinator of this project, Carmen Sánchez, is the president of this association in which representatives of other project partners also act as directors. Specifically, the CTP (Centre Technique du Papier) from France; CIDAUT (Fundación para la Investigación y Desarrollo en Transporte y Energía), from Spain; CENTI (Centre for Nanotechnology and Smart Materials), from Portugal, and the law firm Gil & Robles - San Bartolome & Associés, from Luxembourg.

The BIONANOPOLYS SEP will reduce the risks and barriers to the commercial exploitation of bio-based materials and polymeric bionanocomposites with nanotechnology and accelerate market penetration and innovation processes. SMEs, large companies, and potential customers who are users of the BIONANOPOLYS OITB (Open Innovation Test Bed) will be able to access the services offered by the project partners through this entity, which will act as a one-stop shop, at affordable costs and conditions.

The test bed consists of 14 enhanced pilot plants and complementary services to support technological and commercial breakthroughs. Collaboration between all the partners that make up BIONANOPOLYS and access through the SEP allows joint access to all the services offered by the partners and helps to drive collaborative open innovation.

Call for access to the BIONANOPOLYS OITB
The SEP and the project partners will be in charge of evaluating the projects submitted to the BIONANOPOLYS platform once the open call launched last February to select five projects from different European countries that will be able to access its services free of charge to develop, test or scale-up bionanomaterials in the BIONANOPOLYS OITB closes.

Companies wishing to access the services to develop or test nanomaterials can submit their applications until 30 April.

The BIONANOPOLYS test bed could benefit companies involved in the production of biopolymers, cellulose paper, nonwovens, foams, or coatings, as well as the packaging, agriculture, food, cosmetics, pharmaceuticals, hygiene, textiles and 3D printing sectors.

The international nonwovens community came together once again in Geneva this week for INDEX™23, with with 12,017 attendees from over 100 countries and 610 exhibitors from 43 countries joining the event.

Exhibitors made the most of the four intensive days to meet potential new customers and extend business with existing clients. As one of the world’s leading nonwovens exhibitions, INDEX™ demonstrated the latest breakthroughs and innovative developments across all nonwovens’ applications.

The INDEX™ Lab, an exchange hub displaying samples from innovations and new developments, also showcased the winners and runners up from each of the five categories of the INDEX™ Innovation Award. Open to any EDANA member company or exhibitor at INDEX™23, the winners were announced on the first day of the exhibition during a dedicated ceremony at the EDANA stand.

The winners (more infomation):

1. Nonwoven roll goods
   Winner: Suominen – HYDRASPUN® Circula Nonwoven
2. Finished products made from, or incorporating nonwovens
   Winner: Henkel – Smart Adult Care
3. Raw materials or components (e.g., fibre, binder, polymer, tape), of special relevance to the nonwovens industry and related converted products
   Winner: Fiberpartner – BicoBio
4. Innovation in machinery of special relevance to the nonwovens industry
   Winner: Curt G. Joa, Inc. – ESC-8™
5. Sustainable Product
   Winner: Sparkle Innovations – SugaFluff™

The "Nonwovens Journey", an immersive experience that takes a look at the innovative role of nonwovens, as well as how innovation has progressed in time around both sustainability, and how nonwovens are used in everyday life, also allowed visitors to discover the versatility of nonwovens.

Running alongside the exhibition itself, there was also a full programme of side events that were enjoyed by participants: Exhibitor Product Presentations from 33 exhibitors; a series of informative seminars covering a myriad of topics including medical nonwovens, sustainability, circular economy, geosynthetics, textiles, mobility, fair trade, gender equity, innovation, and market trends; country-specific briefings offering insights into the nonwovens market in various regions around the world; and a nonwovens tutorial intended as an induction to nonwovens for those new to the industry. These topics were all presented by leading industry experts and guest speakers, including among others, the World Trade Organization (WTO).

Concern for the environment has in recent years become increasingly important, and once again remained a key topic at INDEX™23, with companies pushing to achieve further CO₂ reductions and circularity across the supply chain.

Continuing on from its success during COVID-19, the INDEX™23 Mobile App and Virtual Platform was back. This tool offered participants – both in Geneva and those following from home – the chance to watch presentations live and interact with speakers, exhibitors, and other participants. Attendees were able to plan their visit and organize meetings, which was highly appreciated. Video recordings from the sessions will remain available online in the app and platform for the coming weeks.

The next INDEX™ will take place in three years from 21-24 April 2026.

Seit Anfang 2023 gilt das Lieferkettensorgfaltspflichtengesetz für Unternehmen mit mehr als 3.000 Mitarbeitern, ab Anfang 2024 dann auch für Unternehmen mit mehr als 1.000 Beschäftigten. Um betroffenen und interessierten Unternehmen Hilfestellung beim Umsetzen der damit verbundenen Aufgaben zu geben, veranstaltete der BTE am 20. April 2023 ein kostenfreies Webinar mit über 30 Teilnehmern aus Handel, Industrie, Verbänden und Dienstleistungsunternehmen. Referent war Malte Drewes, Berater vom Helpdesk Wirtschaft & Menschenrechte, dessen Ausführungen durch Praxis-Insights von Fabian Nendza, Senior Sustainability Manager bei Frilufts Retail Europe/Globetrotter, ergänzt wurde. Zentrale Aussagen:

• Betroffene Unternehmen müssen ein Risikomanagementsystem installieren. Dazu zählt u.a. die Festlegung von Zuständigkeiten, die Benennung von Ansprechpartnern auf der Website, die Erstellung einer Risikoanalyse, die Installation eines Beschwerdeverfahrens und die Erstellung bzw. Veröffentlichung einer Grundsatzerklärung. Zudem gibt es Dokumentations- und Berichtspflichten für die Aktivitäten.
• Maßnahmen müssen angemessen und wirksam sein. Es gibt allerdings keine Garantiepflicht, dass die Maßnahmen tatsächlich erfolgreich sind, sondern nur eine Bemühenspflicht.
• Als Hilfestellung für Unternehmen wurden bereits einige Handreichungen des Bundesamts für Wirtschaft und Ausfuhrkontrolle (BAFA) unter www.bafa.de/lieferketten erstellt. Demnächst erscheint eine weitere Handreichung zur Zusammenarbeit in der Lieferkette.
• Weitere Hilfen wie den „KMU-Kompass“ oder den „CSR Risiko-Check“ bietet die Agentur für Wirtschaft & Entwicklung unter www.wirtschaft-entwicklung.de.

 
Hinweis: Die gezeigten Charts können auf der BTE-Website www.bte.de, Rubrik: News, eingesehen werden.

Der Vorsitzende des Gemeinsamen Bundesausschusses (G-BA), Prof. Josef Hecken, hat sich auf der BVMed-Mitgliederversammlung am 18. April 2023 in Berlin für ein Beratungsrecht der Medizinprodukte-Hersteller für die anstehenden Studien zum Nutzennachweis für die Erstattungsfähigkeit der „sonstigen Produkte zur Wundbehandlung“ und für die Verlängerung der Übergangsfrist ausgesprochen. „Wir müssen gemeinsam für das Beratungsrecht kämpfen. Dann haben wir die Basis für die Entwicklung von geeigneten Studienkriterien und müssen solange die Übergangsregelung verlängern“, so Heckens Appell an den Gesetzgeber.

Der BVMed hatte sich wiederholt für ein Beratungsrecht beim G-BA analog zum Arzneimittelbereich ausgesprochen, „um Klarheit und Sicherheit beim Antragsprozess, aber insbesondere zu den Anforderungen an Evidenz und Nutzennachweise zu schaffen“, so BVMed-Ambulant-Expertin Juliane Pohl.

Hintergrund ist, dass für jedes einzelne sogenannte „sonstige Produkt zur Wundbehandlung“ künftig der Nachweis der medizinischen Notwendigkeit im Rahmen eines Antragsverfahrens durch den Hersteller beim G-BA durchgeführt werden muss, bevor das jeweilige Produkt durch die Gesetzliche Krankenversicherung (GKV) erstattet wird. Der G-BA hat bislang jedoch keine Klarheit geschaffen, welche Evidenzkriterien in der Wundversorgung für die erstattungsrelevanten Nutzennachweise Anwendung finden. Im Gesetz fehlt ein entsprechender Beratungsanspruch der Hersteller beim G-BA, der Klarheit in diesen komplexen Fragestellungen schaffen könnte. Betroffen von der neuen Regelung ist eine Vielzahl von Produkten wie etwa silber- oder PHMB-haltigen Wundauflagen, die bislang erstattungsfähig waren. Nach Einschätzung des BVMed sind rund 400 Produkte betroffen, für die – bis Dezember 2023 - ein erfolgreiches Nutzenbewertungsverfahren zur Aufnahme in die Anlage V der geänderten Arzneimittel-Richtlinie erforderlich wird.

Hecken machte bei der BVMed-Mitgliederversammlung deutlich, dass der Gesetzgeber kurzfristig ein Beratungsverfahren für Verbandmittel wie bei den Arzneimitteln einführen müsse – zumal der Komplexitätsgrad bei Studien für Wundversorgungsprodukte höher und die Studien-Endpunkte komplexer seien als bei Arzneimitteln. Beispielsweise sei die Frage, wie die Verringerung der Wundgröße dargestellt werden könne, methodisch noch nicht geklärt. „Es ist nicht nur im Interesse der Unternehmen, sondern auch im Interesse des G-BA, wenn möglich schon vor dem Beginn von Studien ein Austausch über das Setting und die Endpunkte solcher Studien stattfindet, damit diese am Ende auch tatsächlich verwertbare Evidenz liefern können“, so Hecken. Auch müsste dann noch die Übergangsfrist entsprechend verlängert werden, damit die Hersteller eine Studie auf Basis des mit dem G-BA besprochenen Studiendesigns durchführen können, um schließlich auf dieser Basis den Antrag zur Aufnahme des Produkts in die Anlage V der Arzneimittel-Richtlinie zu stellen. Nach Hecken müssten Verfahren und Regelungsrahmen zudem geeignet sein, um Innovationen den Zugang in die Versorgung zu ermöglichen.

Der BVMed hatte Anfang April 2023 in einem Brandbrief an Bundesgesundheitsminister Karl Lauterbach „dringenden gesetzlichen Handlungsbedarf bei der Wundversorgung im GKV-System“ angemahnt.

Handele der Gesetzgeber nicht, sei absehbar, dass anerkannte, bewährte sowie auf randomisierten kontrollierten Studien basierende Wundauflagen ab dem 2. Dezember 2023 nicht mehr für die Versorgung der chronisch kranken Wundpatient:innen zur Verfügung stehen. Dies werde nach Angaben der BVMed-Expert:innen dramatische Folgen haben:

• Durch den Wegfall entsprechender antimikrobieller Wundversorgungsprodukte werden durch den absehbar höheren Einsatz oraler Antibiotikatherapien die entsprechenden Resistenzen deutlich steigen.
• Ohne den zukünftigen Einsatz der etablierten Wundauflagen mit antimikrobieller Wirkung wird die Anzahl von stationären Aufenthalten unvermeidlich steigen.
• Außerdem wird der Wegfall insbesondere von antimikrobiellen Wundauflagen zu einer zusätzlichen Belastung der Pflege führen.

DyStar announces the plan to restructure its Ludwigshafen facility located in Germany. The strategic decision is made by the company in response to changing business conditions and market shifts.

Mr. Xu Yalin, Managing Director, and President of DyStar Group said, “This is an important strategic move for DyStar. We will focus on developing key emerging markets, which have been shifting over a decade. In the wake of higher energy costs and inflation, DyStar is determined to further improve cost efficiency and drive sustainable productivity as we continue to deliver the highest quality of innovative products that support the global supply chain.”

Mr. Eric Hopmann, Chief Commercial Officer of DyStar Group said, “The restructuring of this facility will be carried out in a phased manner. DyStar will diversify the production activity out of Europe and start with the reduction of manpower as a consequence. DyStar’s customers can be further assured of undisrupted supply, hence their production should not be affected as we will work closely to meet their specific requirements.”

The facility has been an integral part of DyStar’s global network. DyStar inherited this facility from their founders who started the Indigo research and manufacturing more than 125 years ago.

Freudenberg Performance Materials Apparel (Freudenberg) launches its biodegradable fusible cotton shirt interlinings range 46xx. With this innovation, the world’s leading specialist in woven, knitted, weft and nonwoven interlinings reduces its impact on the environment and supports customers in achieving their own sustainability objectives. In Asia, the series is marketed under the name 42xx series.

Approved biodegradability and non-toxicity by Hohenstein Laboratories
The new Freudenberg fusible interlinings for shirts and blouses have been developed in such a way that they are harmless to people and the environment at the end of their life cycle. Germany’s independent Hohenstein Laboratories performed biodegradation tests on the 46xx series, based on the Hohenstein method which draws on DIN EN ISO 11721-2:2003 and EN ISO 846, and approved it as biodegradable and ecotoxicologically harmless. The tests by Hohenstein showed no negative effects on either the germination of garden cress nor on earthworms in the acute toxicity test.

Energy-saving interlining
The new biodegradable shirt interlinings also show great potential for energy saving, as the fusing can be performed at a low temperature. Concretely, this means that the resulting temperature between the upper fabric and the shirt interlining during fusing is only 127°C which is significantly lower than the commonly used temperature of 143°C. Certified to OEKO-TEX® STANDARD 100 Class II for successfully testing for no harmful substances, the shirt interlinings are washable at up to 40°C and resistant to dry cleaning. In addition, it has also passed all ecological-toxicological tests and is a perfect end-of-life cycle solution.

Product details and availability
The products in range 46xx are available in Europe in the color white and the following weight classes: 4605 (90g/m2), 4616 (150g/m2) and 4618 (55g/m2). The adhesive of the interlinings consists of a 100% degradable bio-polymer. The shirt interlinings are ideal for reinforcing shirt and blouse collars, cuffs and plackets used in fashion, leisure and business clothing. The biodegradable, non-toxic interlinings are particularly important for labels with an ecologically sustainable claim.